The Emerging Role of Amyloid PET Imaging in the Clinical Diagnosis and Management of Dementia

03/8/2013

Join SNMMI and the American Association for Geriatric Psychiatry for an informative session on the clinical use of amyloid PET imaging for dementia, March 16 from 2:45 to 4:15 pm at the JW Marriott in L.A. Live in Los Angeles. John Seibyl, MD, Peter Herscovitch, MD, and Norman Foster, MD, will update participants on the clinical implementation of recently approved PET radiotracers for detecting brain amyloid deposition. Onsite registration begins today, March 13.

View Full Article in:

http://www.aagponline.org/clientuploads/AAGP13%2520Final%2520program%25202-25%25...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA